May we introduce 
ourselves

• Founder and General Manager, be executive GmbH
• General Manager, Merck Serono GmbH, Germany
• Senior VP Europe, Merck KGaA
• Managing Director & General Manager, Merck s.a. Portugal

In the industry since 1991, in the company from 1991 to 1996 and again since 1997: 

• Director Market Access (UCB Pharma GmbH)
• Director Marketing (Schwarz Pharma Deutschland GmbH)
• Product Manager & Head of Marketing Vascular (Schwarz Pharma Deutschland GmbH)

On the Supervisory Board since: April 2021 
Elected until 2027 

• Lawyer and serial entrepreneur
• Chief Executive Officer, Perspix Biotech GmbH
• Member of the Executive Board, BioMedion AG

On the Supervisory Board since: April 2021 
Elected until: 2027 

• Management Consultant,

• Vice President Global Business Services Finance, UCB Pharma S.A.,

• Chief Financial Officer, Schwarz Pharma,

• Audit Manager, Deloitte GmbH

On the Supervisory Board since: May 2022 
Elected until: 2027   

• Since 2008 Head of Global Business Development Neurology at UCB Pharma GmbH,

• From 2006 Member of the Corporate Business Development at UCB Pharma GmbH,

• From 2005 Activity for the BD & Licensing Team of Schwarz Pharma AG 

On the Supervisory Board since: April 2021 
Elected until: 2027 

• Since 2004: Founding partner, Paragon Partners,

• Partner, Triton Partners,

• Partner, Drueker & Co.,

• Arthur Andersen LLP

On the Supervisory Board since: April 2021 
Elected until: 2027 

• Since 2014: Paragon Partners
• Head of Strategy/Data/Project Management, CLIQZ
• McKinsey & Company
• Siemens AG